Search
Disease factsheet about pneumococcal disease
Despite good access to effective antibiotics, Streptococcus pneumoniae (pneumococci) is still a major cause of disease and death in both developing and developed countries. Pneumococci are the main cause of bacterial respiratory tract infections, such as pneumonia, middle ear infection, and sinusitis, in all age groups.
Data
ECDC Vaccine Scheduler
The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups. With this tool comparisons can be made for vaccination schedules between two countries or by disease for all or a selection of countries.
- Diphtheria
- Europe
- Hepatitis A
- Hepatitis B
- Human papillomavirus infection
- Immunisation
- Influenza in humans, seasonal
- Invasive Haemophilus influenzae disease
- Measles
- Meningococcal disease
- Pertussis
- Pneumococcal disease
- Poliomyelitis
- Prevention and control
- Rotavirus infection
- Rubella
- Tetanus
- Tick-borne diseases
- Tuberculosis
- Varicella
Data
Table 1. Reported confirmed cases of invasive pneumococcal disease cases: number and rate per 100 000 population, EU/EEA, 2010–2014
Reported confirmed cases of invasive pneumococcal disease cases: number and rate per 100 000 population, EU/EEA, 2010–2014
Data
Figure 2. Number of reported confirmed cases of invasive pneumococcal disease per 100 000 population, EU/EEA, 2014
Number of reported confirmed cases of invasive pneumococcal disease per 100 000 population, EU/EEA, 2014
Data
Figure 3. Reported confirmed cases of invasive pneumococcal disease cases, by age and gender, EU/EEA, 2014
Reported confirmed cases of invasive pneumococcal disease cases, by age and gender, EU/EEA, 2014
Data
Figure 4. Seasonal distribution of reported confirmed cases of invasive pneumococcal disease, EU/EEA, 2014 compared with 2010−2013
Seasonal distribution of reported confirmed cases of invasive pneumococcal disease, EU/EEA, 2014 compared with 2010−2013
Data
Figure 5. Trend and number of reported confirmed cases of invasive pneumococcal disease, EU/EEA, 2010−2014
Trend and number of reported confirmed cases of invasive pneumococcal disease, EU/EEA, 2010−2014
Data
Figure 6. Distribution of confirmed cases of invasive pneumococcal disease: most common serotypes in 2014 (n=12 980), 2013 (n=14 811) and 2012 (n=14 845)
Distribution of confirmed cases of invasive pneumococcal disease: most common serotypes in 2014 (n=12 980), 2013 (n=14 811) and 2012 (n=14 845)
Data
Table 2. Proportion of the five most frequent serotypes among confirmed cases of invasive pneumococcal disease, by age group, 2014 (n= 12 898*)
Proportion of the five most frequent serotypes among confirmed cases of invasive pneumococcal disease, by age group, 2014 (n= 12 898*)